SE5292304T3 - - Google Patents

Info

Publication number
SE5292304T3
SE5292304T3 SE01930705T SE01930705T SE5292304T3 SE 5292304 T3 SE5292304 T3 SE 5292304T3 SE 01930705 T SE01930705 T SE 01930705T SE 01930705 T SE01930705 T SE 01930705T SE 5292304 T3 SE5292304 T3 SE 5292304T3
Authority
SE
Sweden
Prior art keywords
polymorphs
preparation
provides
present
zolpidem hemitartrate
Prior art date
Application number
SE01930705T
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27394001&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SE5292304(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of SE5292304T3 publication Critical patent/SE5292304T3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Other Liquid Machine Or Engine Such As Wave Power Use (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Supply Devices, Intensifiers, Converters, And Telemotors (AREA)
  • Suspension Of Electric Lines Or Cables (AREA)
  • Amplifiers (AREA)
SE01930705T 2000-04-24 2001-04-24 SE5292304T3 (cs)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US19929800P 2000-04-24 2000-04-24
US20602500P 2000-05-22 2000-05-22
US22536400P 2000-08-14 2000-08-14

Publications (1)

Publication Number Publication Date
SE5292304T3 true SE5292304T3 (cs) 2005-11-02

Family

ID=27394001

Family Applications (1)

Application Number Title Priority Date Filing Date
SE01930705T SE5292304T3 (cs) 2000-04-24 2001-04-24

Country Status (21)

Country Link
US (8) US20020077332A1 (cs)
EP (1) EP1292304B1 (cs)
JP (3) JP2003531173A (cs)
KR (1) KR20030069796A (cs)
AT (4) ATE348613T1 (cs)
AU (2) AU5721301A (cs)
CA (1) CA2406982A1 (cs)
CZ (1) CZ20023775A3 (cs)
DE (7) DE60122944T2 (cs)
DK (1) DK1292304T3 (cs)
ES (4) ES2239558T3 (cs)
HR (1) HRP20020909A2 (cs)
HU (1) HUP0300701A2 (cs)
IL (1) IL152411A0 (cs)
NZ (1) NZ522015A (cs)
PL (1) PL358548A1 (cs)
PT (3) PT1473036E (cs)
SE (1) SE5292304T3 (cs)
SK (1) SK16372002A3 (cs)
WO (1) WO2001080857A1 (cs)
YU (1) YU79402A (cs)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6921839B2 (en) 2000-08-29 2005-07-26 Ranbaxy Laboratories Limited Synthesis of N,N-dimethyl-3-(4-methyl) benzoyl propionamide a key intermediate of zolpidem
US6869970B2 (en) 2002-02-04 2005-03-22 Novartis Ag Crystalline salt forms of valsartan
CN100398539C (zh) 2002-12-18 2008-07-02 马林克罗特公司 杂芳基乙酰胺的合成
WO2004087703A1 (en) * 2003-03-12 2004-10-14 Sun Pharmaceutical Industries Limited Process for the preparation of n,n,6-trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide
EP1660496A1 (en) * 2003-07-31 2006-05-31 Ranbaxy Laboratories Limited Process for the synthesis of zolpidem
US7658945B2 (en) * 2004-02-17 2010-02-09 Transcept Pharmaceuticals, Inc. Compositions for delivering hypnotic agents across the oral mucosa and methods of use thereof
WO2006008636A2 (en) * 2004-07-16 2006-01-26 Ranbaxy Laboratories Limited Processes for the preparation of zolpidem and its hemitartrate
NZ563979A (en) * 2005-05-25 2011-02-25 Transcept Pharmaceuticals Inc Solid compositions and methods for treating middle-of-the night insomnia
US20070225322A1 (en) * 2005-05-25 2007-09-27 Transoral Pharmaceuticals, Inc. Compositions and methods for treating middle-of-the night insomnia
US20070287740A1 (en) * 2005-05-25 2007-12-13 Transcept Pharmaceuticals, Inc. Compositions and methods of treating middle-of-the night insomnia
BRPI0615357A2 (pt) * 2005-08-19 2011-05-17 Aventis Pharma Inc combinação de um agente hipnótico e r (+)-alfa-(2,3-dimetóxi-fenil)-1-[2-(4-fluorofenil)etil]-4-pi peridinometanol e aplicação terapêutica do mesmo
ATE447400T1 (de) * 2005-08-19 2009-11-15 Aventis Pharma Inc Kombination aus einem hypnotischen mittel und einer substituierten bis-aryl- und heteroaryl- verbindung und ihre therapeutische anwendung
CA2624340A1 (en) * 2005-10-03 2007-04-12 Mallinckrodt Inc. Process for preparing zolpidem hemitartrate and tartrate polymorphs
JP2009511627A (ja) * 2005-10-17 2009-03-19 マリンクロッド・インコーポレイテッド 錠剤マトリックスにおけるゾルピデムの多形転移
US20070098788A1 (en) * 2005-10-28 2007-05-03 Gore Subhash P Non-benzodiazepine hypnotic compositions
JP5066175B2 (ja) 2006-03-31 2012-11-07 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ヒスタミンｈ４受容体のモジュレーターとしてのベンゾイミダゾール−２−イルピリミジンおよびピラジン
WO2008067549A2 (en) * 2006-11-30 2008-06-05 Transcept Pharmaceuticals, Inc. Stabilized zolpidem pharmaceutical compositions
US20080145425A1 (en) * 2006-12-15 2008-06-19 Pliva Research & Development Limited Pharmaceutical composition of zolpidem
US9371311B2 (en) 2008-06-30 2016-06-21 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine derivatives
EP2865678A3 (en) * 2008-06-30 2015-05-27 Janssen Pharmaceutica NV Crystalline hemi-tartrate form of a benzoimidazol-2-yl pyrimidine derivative
CN105753846B (zh) 2009-11-27 2019-11-15 基酶有限公司 作为葡糖神经酰胺合酶的抑制剂的无定型和结晶形式的Genz 112638半酒石酸盐
WO2011115069A1 (ja) * 2010-03-19 2011-09-22 第一三共株式会社 結晶の網羅的探索
EP2964229B1 (en) 2013-03-06 2019-12-11 Janssen Pharmaceutica NV Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
CN116283958A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦共晶体及其制备方法
CN116283957A (zh) * 2021-12-03 2023-06-23 山东新时代药业有限公司 唑吡坦水合物及其制备方法
CN117907368A (zh) * 2024-01-27 2024-04-19 鲁南贝特制药有限公司 一种酒石酸唑吡坦药用晶型d中晶型a、e的定量测定方法
CN118750459B (zh) * 2024-07-22 2025-04-01 常州市武进中医医院 一种酒石酸唑吡坦片及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
IT1130924B (it) * 1980-03-06 1986-06-18 Secifarma Spa Procedimento per la preparazione di spironolattone micronizzato
DE3018940A1 (de) * 1980-05-17 1981-11-26 Hoechst Ag, 6000 Frankfurt Verwendung eines vinylchlorid-pfropf-copolymerisates in der plastisolverarbeitung
FR2492382A1 (fr) * 1980-10-22 1982-04-23 Synthelabo Derives d'imidazo (1,2-a) pyridine, leur preparation et leur application en therapeutique
FR2525601A1 (fr) * 1982-04-21 1983-10-28 Synthelabo Derives d'imidazo(1,2-a)pyridines, leur preparation et leur application en therapeutique
US4675323A (en) * 1985-08-06 1987-06-23 Synthelabo Imidazo(1,2-a)quinoline derivatives useful as anxiolytic agents
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
FR2600650B1 (fr) * 1986-06-27 1988-09-09 Synthelabo Procede de preparation d'imidazopyridines et composes intermediaires
FR2606410B1 (fr) * 1986-11-07 1989-02-24 Synthelabo Imidazopyridines, leur preparation et leur application en therapeutique
EP0289371B1 (fr) * 1987-03-27 1991-09-25 Synthelabo Dérivés d'imidazopyridines, leur préparation et leur application en thérapeutique
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
IT1276522B1 (it) * 1995-04-07 1997-10-31 Elena Benincasa Uso dello zolpidem per il trattamento terapeudico di sindromi neuropsichiatriche associate a disfunsione e di circuiti neurali dei
NL1014634C1 (nl) * 1999-03-25 2000-08-03 Synthon Bv Zolpidemzouten.
EP1038875B1 (en) * 1999-03-25 2003-06-04 Synthon B.V. Imidazopyridine derivatives and process for making them
AU6474200A (en) * 1999-12-13 2001-06-18 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound

Also Published As

Publication number Publication date
YU79402A (sh) 2006-03-03
KR20030069796A (ko) 2003-08-27
DE60122216T2 (de) 2007-08-30
HUP0300701A2 (hu) 2003-07-28
US20040214858A1 (en) 2004-10-28
DE04010651T1 (de) 2005-09-01
ATE348613T1 (de) 2007-01-15
ES2238941T3 (es) 2007-04-01
DE04010435T1 (de) 2005-09-01
US20070037843A1 (en) 2007-02-15
AU2001257213B2 (en) 2005-09-29
PL358548A1 (en) 2004-08-09
JP2006249105A (ja) 2006-09-21
EP1292304B1 (en) 2005-11-02
ES2277301T3 (es) 2007-07-01
ES2238941T1 (es) 2005-09-16
NZ522015A (en) 2004-08-27
US20020077332A1 (en) 2002-06-20
IL152411A0 (en) 2003-05-29
US20040220210A1 (en) 2004-11-04
JP2006137778A (ja) 2006-06-01
DE60114617D1 (de) 2005-12-08
DE60125429D1 (de) 2007-02-01
PT1475093E (pt) 2006-11-30
JP2003531173A (ja) 2003-10-21
DE60122216D1 (de) 2006-09-21
ATE308324T1 (de) 2005-11-15
SK16372002A3 (sk) 2003-04-01
AU5721301A (en) 2001-11-07
HRP20020909A2 (en) 2004-08-31
DE60125429T2 (de) 2007-09-27
US20040214859A1 (en) 2004-10-28
ES2239558T1 (es) 2005-10-01
ES2248321T3 (es) 2006-03-16
CA2406982A1 (en) 2001-11-01
PT1541146E (pt) 2007-01-31
WO2001080857A9 (en) 2002-06-27
US20040220211A1 (en) 2004-11-04
PT1473036E (pt) 2006-10-31
ATE335481T1 (de) 2006-09-15
CZ20023775A3 (cs) 2003-10-15
US20040220213A1 (en) 2004-11-04
DE60122944T2 (de) 2007-04-12
EP1292304A1 (en) 2003-03-19
US20040220212A1 (en) 2004-11-04
ATE338550T1 (de) 2006-09-15
ES2239558T3 (es) 2007-04-01
DE60122944D1 (de) 2006-10-19
EP1292304A4 (en) 2003-07-23
DE60114617T2 (de) 2006-07-27
DK1292304T3 (da) 2005-12-19
WO2001080857A1 (en) 2001-11-01
DE20122435U1 (de) 2005-10-06

Similar Documents

Publication Publication Date Title
IL152411A0 (en) Zolpidem hemitartrate
PL374884A1 (en) Preparation of 1h-imidazo[4,5-c]quinolin-4-amines via 1h-imidazo[4,5-c]quinolin-4-phthalimide intermediates
MXPA03011197A (es) Benzoilsufonamidas y sulfonilbenzamidinas que se usan como agentes antitumorales.
AU3276802A (en) Background of the invention
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
AU3877500A (en) Methods for preparing 3-aryloxy-3-arylpropylamines and intermediates thereof
JO2410B1 (en) 6. Replaced pyrido-pyrimidines
MY130718A (en) Antitumor compounds and methods
MXPA03007834A (es) Uso de agonistas inversos de gabaa, en combinacion con agonistas parciales del receptor de nicotina, estrogenos, moduladores selectivos de estrogenos o vitamina e, para el tratamiento de transtornos cognitivos.
IL153680A0 (en) Aplidine derivatives and methods for the preparation thereof
PL368195A1 (en) Tricyclic imidazopyridines
MXPA04003755A (es) Endoprotesis vasculares.
AU6279500A (en) Epothilone compositions
MXPA04000541A (es) Formulacion liofilizada de 2-metil-tieno-benzodiazepina.
MY127474A (en) Naphthyl compounds, intermediates, compositions, and methods of use
AU2003285485A1 (en) 5 ANDROSTEN-3Beta-OL STEROID INTERMEDIATES AND PROCESSES FOR THEIR PREPARATION
MXPA04004757A (es) Uso de una ascomicina para el tratamiento de blefaritis.
IL157607A0 (en) Methods for the preparation of mirtazapine intermediates
MXPA03005400A (es) Metodo para preparacion de 11 (12)-pentadecen-15-olidos.
RS20050543A (en) Process and intermediates for the preparation of olanzapine
UA33933A (uk) Лімфогінний засіб
HK1071509A (en) Use of an ascomycin for the treatment of blepharitis
AU2002238815A1 (en) Device for the partial annealing of machined mechanical parts
SI1250335T1 (sl) Postopek in intermediati za pripravo imidazopiridinov
AU2001223871A1 (en) Methods for the treatment of ibs